TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities July 28, 2000
TCL Archive Senate Investigates Opioid Manufacturers, Requests Study of Impact of DEA Policies May 11, 2012
TCL Archive Organization Can Compete For Both Major FCRC Contracts, RFP Out Next June September 12, 1980
